SERUM ANTI- MULLERIAN HORMONE IS A BETTER PREDICTOR OF OVARIAN RESERVE AT THE EARLY FOLLICULAR PHASE.

Correlation Between Serum Anti-Müllerian Hormone Levels and Antral Follicle Count in Prediction of Clinical Pregnancy in Women with Unexplained Infertility Undergoing ICSI Cycles

Using Anti-Müllerian Hormone and Serum Estradiol to Predict Ovarian Hyperstimulation Syndrome in Patients Using Antagonist Protocol During IVF/ICSI Cycles

Comparative Study of Anti-Mullerian Hormone, inhibin-B, and Three-Dimensional Ultrasound Determinants of Ovarian Reserve in Patients Undergoing ICSI

The Predictive Value of Anti-Mullerian Hormone on Pregnancy Rate After IVF

Antral Follicle Count versus Basal Follicle Stimulating Hormone as Predictors of Ovarian Response in Women Undergoing Superovulation with Long Protocol for Assisted Reproduction

Comparative Study Between Ovarian Response Prediction Index Versus Anti-Müllerian Hormone, Antral Follicular Count as Predictors of Ovarian Response in Women Undergoing IVF/ICSI Cycles

EVALUATION OF THE ROLE OF ANTIMULLERIAN HORMONE (AMH), FOLLICLE STIMULATING HORMONE (FSH) AND ANTRAL FOLLICLE COUNT (AFC) AS A PREDICTOR FOR CYCLE CANCELLATION IN WOMEN DURING ANTAGONISTIC PROTOCOL FOR ICSI

Anti-Müllerian Hormone Based Protocol Versus The Traditional Protocol For in-Vitro Fertilization/ Intracytoplasmic Sperm Injection: A Randomized Controlled Trial

Correlation Between Anti Mullerian Hormone Level and Antral Follicle Count Using Three-Dimensional Ultrasound in Cases of Recurrent Spontaneous Abortion